News

The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the ...
In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...
In the fourth part of this roundtable discussion, a panel of subject matter experts dive into data exchange challenges relating to the Drug Supply Chain Security Act.
Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...
Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...
In the fourth part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data Science, outlines what he anticipates for the biosimilar adoption curve in ...
In the third part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...
In the first part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...
The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...
In the third part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, recommends regulatory or verification mechanisms that can help safely ...
The industry veteran will lead the company’s next phase of growth, focusing on faster treatment initiation through integrated ...
Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.